Skip to main content
Molecular Therapy Oncolytics logoLink to Molecular Therapy Oncolytics
. 2023 Oct 23;31:100738. doi: 10.1016/j.omto.2023.100738

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

Marije AJ de Rooij , Dennis FG Remst, Dirk M van der Steen, Anne K Wouters, Renate S Hagedoorn, Michel GD Kester, Miranda H Meeuwsen, Tassilo LA Wachsmann, Arnoud H de Ru, Peter A van Veelen, Els ME Verdegaal, JH Frederik Falkenburg, Mirjam HM Heemskerk ∗∗
PMCID: PMC10618812  PMID: 37920174

Main text

(Molecular Therapy: Oncolytics 28, 1–14; March 2023)

In the originally published version of this article, there was an error in Figure 4B. In the graph second from the top, MAGE-A1 LTQ/A1 is indicated in black, but instead this should be MAGE-A1 KVL/A2.

This error has been corrected in the figure online, and the authors apologize for any confusion this may have caused.

graphic file with name gr4o.jpg

Figure 4. TCR expression and cytotoxicity of transduced primary CD8⁺ T cells against malignant cell lines (original)

graphic file with name gr4c.jpg

Figure 4. TCR expression and cytotoxicity of transduced primary CD8⁺ T cells against malignant cell lines (corrected)

Contributor Information

Marije A.J. de Rooij, Email: m.a.j.de_rooij@lumc.nl.

Mirjam H.M. Heemskerk, Email: m.h.m.heemskerk@lumc.nl.


Articles from Molecular Therapy Oncolytics are provided here courtesy of American Society of Gene & Cell Therapy

RESOURCES